| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/12/2006 | EP1645556A1 Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents |
| 04/12/2006 | EP1644365A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 04/12/2006 | EP1644334A1 Antithrombotic ethers |
| 04/12/2006 | EP1644333A1 In-situ treatment of pyridine-2,3-dicarboxylic acid esters with an oxidizing agent |
| 04/12/2006 | EP1644332A1 Diarylmethyl derivatives as potassium channel modulators |
| 04/12/2006 | EP1644331A1 A method for producing 1,3-dialkylpyridinium oligomers and related compounds using a solid support |
| 04/12/2006 | EP1644330A2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 04/12/2006 | EP1644326A1 Cathepsin cysteine protease inhibitors |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1418879B1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1039897B1 Inadone and tetralone compounds for inhibiting cell proliferation |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759120A Metal complexes |
| 04/12/2006 | CN1757637A Method for purifying VE nicotinate raw material |
| 04/12/2006 | CN1250735C Method for production of non-proteinogen L-amino acid by fermentation |
| 04/12/2006 | CN1250559C Process for preparing amine platinum complexes |
| 04/12/2006 | CN1250540C Improved single-reactor synthesis of [2,8-di(trifluoromethyl)-4-quinolyl]-2-pyridyl methyl ketone and methylfluoro quine |
| 04/12/2006 | CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 04/12/2006 | CN1250527C Process for large-scale preparation of 2-vinyl pyridine |
| 04/12/2006 | CN1250519C Amine derivative with K channel regulation function and its preparing process and application |
| 04/12/2006 | CN1250518C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application |
| 04/12/2006 | CN1250498C Process for fluorinating aromatic ring compounds |
| 04/12/2006 | CN1250192C 2, 5-diaminopyridine oxidation color display alkali for dyeing keratin fiber |
| 04/11/2006 | US7026498 Coordination catalyst containing ligand |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026479 Process for the production of quinazolines |
| 04/11/2006 | US7026478 Iron catalyzed cross coupling reactions of aromatic compounds |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026459 Azo dyes |
| 04/11/2006 | US7026340 substituted by a pyridinylmethyl- group, e.g., 2-allyl-2-((6-Chloro-3-pyridyl)methyl)malononitrile; insecticides, nematocides, miticides |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | US7026338 Pharmaceutical nitrones |
| 04/11/2006 | US7026307 Decyclization of a 1-heterocyclylmethyl-2-nitroimino-1,3,5-hexahydrotriazine compound with hydrogen halide in presence of a nitrile to form a 1-heterocyclylmethyl-2-nitroguanidine compound |
| 04/11/2006 | US7026062 Luminescence device, display apparatus and metal coordination compound |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/06/2006 | WO2006036949A2 Preparation of n-aryl pyridones |
| 04/06/2006 | WO2006035997A1 Compound and organic electroluminescent device using same |
| 04/06/2006 | WO2006035967A1 Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor |
| 04/06/2006 | WO2006035760A1 Drug for treating skin disease |
| 04/06/2006 | WO2006035759A1 Drug for treating respiratory disease |
| 04/06/2006 | WO2006034797A1 Thermodynamically stable form of bay 43-9006 tosylate |
| 04/06/2006 | WO2006034796A1 Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-n-methylpyridine-2-carboxamide |
| 04/06/2006 | WO2005065195A3 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/06/2006 | US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors |
| 04/06/2006 | US20060074246 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074111 Chemical compounds |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2006 | US20060074100 Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases |
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/06/2006 | US20060073541 Lipophilic dyes and their application for detection of myelin |
| 04/06/2006 | US20060073358 Cyclometalated transition metal complex and organic electroluminescent device using the same |
| 04/05/2006 | EP1642880A1 Hsp90 family protein inhibitors |
| 04/05/2006 | EP1641800A1 Pyrazolopyrimidines |
| 04/05/2006 | EP1641798A1 Triazolopyrimidines |
| 04/05/2006 | EP1641759A2 Malonamide derivatives |
| 04/05/2006 | EP1641758A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 04/05/2006 | EP1641745A1 Propionamide derivatives useful as androgen receptor modulators |
| 04/05/2006 | EP1641740A1 Method for producing an optically active nitro compound |
| 04/05/2006 | EP1641493A1 Radiolabeled cannabinoid-1 receptor modulators |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1370544B1 Nitric oxide donors based on metallic centres |
| 04/05/2006 | EP1357889B1 Novels couplers for use in oxidative hair dyeing |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1756745A Preparation of 3,6-dichloro-2-trichloromethylpyridine by vapor phase chlorination of 6-chloro-2-trichlormethylpyridine |
| 04/05/2006 | CN1756744A Pyridinium salts, compounds and methods of use |
| 04/05/2006 | CN1756740A Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 04/05/2006 | CN1756728A 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754879A Imidazole derivative compound, its salts and use thereof |
| 04/05/2006 | CN1754877A Anthracene derivative and organic electroluminescence device using the derivative |
| 04/05/2006 | CN1754875A Alkoxyniacin preparation method |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249053C Nitrate salt of anti-ulcer medicine |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/04/2006 | US7024068 Electron-driven chirality switches |
| 04/04/2006 | US7022857 Preparation of substituted aromatic compounds |
| 04/04/2006 | US7022853 Single pot process for preparing metal nicotinates from beta-picoline |
| 04/04/2006 | US7022825 Polyketides and antibiotics |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022695 Thioether-substituted benzamides as inhibitors of Factor Xa |
| 04/04/2006 | US7022421 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 04/04/2006 | CA2359958C Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone |